For job seekers
For companies
Set your preferences and let your AI copilot handle the job search while you sleep.
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: ARV-102 for the treatment of patients with neurodegenerative disorders,ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas, and ARV-806, a KRAS G12D PROTAC for the treatment patients with solid tumors with KRAS G12D mutations.
On August 8th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant.
In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.
#TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.
For more information, please visit www.arvinas.com.
Position Summary
The Clinical Scientist is responsible for providing scientific support for all Global Clinical Development activities. This role includes assembling, evaluating, and presenting scientific and medical data, writing or providing content to clinical documents (clinical study protocols and protocol synopses, papers, abstracts, posters, etc.), monitoring the competitive landscape and reviewing and summarizing relevant literature to provide strategic input. This position requires a strong scientific background; in addition, the candidate must be able to clearly communicate concepts and information both in writing and via formal presentations to scientific and medical experts both internal and external to the company. The Clinical Scientist needs to possess the ability to think creatively, function independently, deliver on timelines, have good strategic insights and have a detailed knowledge of the activities and procedures involved in clinical drug development.The Clinical Scientist will collaborate with Clinical Operations, Translational Sciences, Clinical Pharmacology, Regulatory, Research and other functions within Arvinas, as well as key partners external to the company. Working closely with colleagues in Clinical Development, the Clinical Scientist will have a substantial role in the development of the clinical documents, the review of scientific and clinical data and the communication of data to the scientific and medical communities.
This position reports to the Head of Clinical Sciences and can be hybrid at our headquarters in New Haven, CT, or remote from a location within the U.S.
Principal Responsibilities
Key responsibilities of this role include, but are not limited to:
Clinical Document Development
Clinical Study Planning
Study Data Review and Analysis
Review of Scientific Literature
Qualifications
Required:
Advanced, doctoral level degree preferred such as PhD, MD, MSc/MPH, PharmD, BS/ MS with relevant professional experience may be considered.
Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for current or future VISA sponsorship.
INSERT JOB DESCRIPTION HERE
Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com
Arvinas is an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identify, national origin, disability or protected veteran status.
Help us maintain the quality of jobs posted on Empllo!
Is this position not a remote job?
Let us know!